STN1012600

· Santen Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for STN1012600, covering 2023-12-05 to 2024-07-15. Get the full timeline:

Most recent: Clinical Trial Update: A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension [Phase 3]